Lack of effect of eicosapentaenoic acid in the Porsolt forced swimming test model of depression

Acta Neuropsychiatrica

Volumn 14, Issue 5, 2002, Pages 203-206

  Shaldubina, Alona ^a   Nemets, Boris ^a   Bersudsky, Yuly ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

Author keywords

Depression; Eicosapentenoic acid (EPA); Omega 3; Porsolt forced swimming test

Indexed keywords

FISH OIL; ICOSAPENTAENOIC ACID; IMIPRAMINE; OMEGA 3 FATTY ACID;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; SWIMMING;

EID: 0036811071     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-5215.2002.140501.x     Document Type: Article

References (23)

1. Favreliere S, Barrier L, Durand G, Chalon S, Tallineau C. Chronic dietary ω-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum. Lipids 1998;33:401-407.
2. Connor WE, Neuringer M. The effects of ω-3 fatty acid deficiency and repletion upon the fatty acid composition and function of the brain and retina. Progr Clin Biol Res 1988;282:275-294.
3. Delion S, Chalon S, Guilloteau D, Lejeune B, Besnard JC, Durand G. Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an ω-3 poly-unsaturated fatty acid-deficient diet. J Lipid Res 1997;38:680-689.
4. Nanjo A, Kanazawa A, Sato K, Banno F, Fujimoto K. Depletion of dietary ω-3 fatty acid affects the level of cyclic AMP in rat hippocampus. J Nutr Sci Vitaminol (Tokyo) 1999;45:633-641.
5. Speizer LA, Watson MJ, Brunton LL. Differential effects of omega-3 fish oils on protein kinase activities in vitro. Am J Physiol 1991;261(1 Part 1):E109-114.
6. Salem NJR, Moriguchi T, Greiner RS, McBride K, Ahmad A, Catalan JN, Slotnick B. Alterations in brain function after loss of docosahexaenoate due to dietary restriction of ω-3 fatty acids. J Mol Neurosci 2001;16:299-307.
7. Villarroel A, Schwarz TL. Inhibition of the Kv4 (Shal) family of transient K+ currents by arachidonic acid. J Neurosci 1996;16:1016-1025.
8. Hibbeln JR. Fish consumption and major depression. Lancet 1998;351:1213.
9. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999;85:275-291.
10. Maes M, Smith RS. Fatty acids, cytokines, and major depression. Biol Psychiatry 1998;43:313-314.
11. Chalon S, Delion-Vancassel S, Belzung C, Guilloteau D, Leguisquet AM, Besnard JC, Durand G. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J Nutr 1998;128:2512-2519.
12. Puri BK, Counsell SJ, Hamilton G, Richardson AJ, Horrobin DF. Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. Int J Clin Pract 2001;55:560-563.
13. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB. Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial. Arch General Psychiatry 1999;56:407-412.
14. Rudin DO. The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: Substrate pellagra. Biol Psychiatry 1981;16:837-850.
15. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 Fatty Acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477-479.
16. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M. Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 1979;57:201-210.
17. Danisz W, Archer T, Fowler CJ. Screening for antidepressant compounds. In: Willner P, eds. Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives. Cambridge: Cambridge University Press, 1991:140.
18. Redrobe JP, Bourin M. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test. Psychopharmacol 1998;138:198-206.
19. Renard CE, Fiocco AJ, Clenet F, Hascoet M, Bourin M. Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test? Psychopharmacol 2001;159:42-50.
20. Gorka Z, Wojtasik E, Kwiatek H, Maj J. Action of serotoninmimetics in the behavioral despair test in rats. Commun Psychopharmacol 1979;3:133-136.
21. Nomura S, Shimizu J, Kametani H, Kinjo M, Watanabe M, Nakazava T. Swimming in mice: In search of an animal model for human depression. In: Langer SZ, Takahashi R, Segava T, Briley N, eds. New Vistas in Depression. Oxford: Pergamon Press, 1982:203-210.
22. Danysz W, Plaznik A, Kostowski W, Malatynska E, Jarbe TU, Hiltunen AJ, Archer T. Comparison of desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs. Pharmacol Toxicol 1988;62:42-50.
23. Takamori K, Yoshida S, Okuyama S. Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats. Pharmacol 2001;63:147-153.